SEARCH

SEARCH BY CITATION

References

  • Arnette D., Gibson T. B., Lawrence M. C., January B., Shih K., McGlynn K., Vanderbilt C. A. and Cobb M. H. (2003) Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J. Biol. Chem. 278, 3251732525.
  • Blank T., Nijholt I., Teichert U., Kugler H., Behrsing H., Fienberg A., Greengard P. and Spiess J. (1997) The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc. Natl Acad. Sci. USA 94, 14 85914 864.
  • Bondy C. A. and Cheng C. M. (2002) Insulin-like growth factor-1 promotes neuronal glucose utilization during brain development and repair processes. Int. Rev. Neurobiol. 51, 189217.
  • Brandoli C., Sanna A., De Bernardi M. A., Follesa P., Brooker G. and Mocchetti I. (1998) Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J. Neurosci. 18, 79537961.
  • Britsch S., Krippeit-Drews P., Lang F., Gregor M. and Drews G. (1995) Glucagon-like peptide-1 modulates Ca2+ current but not K+ATP current in intact mouse pancreatic B-cells. Biochem. Biophys. Res. Commun. 207, 3339.
  • Buteau J., Roduit R., Susini S. and Prentki M. (1999) Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol-3-kinase and increases transcription factor pancreatic and homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42, 856864.
  • Calvo J. C., Yusta B., Mora F. and Blazquez E. (1995) Structural characterization by affinity cross-linking of glucagon-like peptide-1(7–36) amide receptor in rat brain. J. Neurochem. 64, 299306.
  • Carro E., Trejo J. L., Busiguina S. and Torres-Aleman I. (2001) Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J. Neurosci. 21, 56785684.
  • Cheng B. and Mattson M. P. (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12, 15581566.
  • Cheng L. L., Wang S. J. and Gean P. W. (1998) Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur. J. Neurosci. 10, 21632172.
  • Cheng G., Yu Z., Zhou D. and Mattson M. P. (2002) Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein. Exp. Neurol. 175, 407414.
  • Choi D. W. (1987) Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369379.
  • Deisseroth K. and Tsien R. W. (2002) Dynamic multiphosphorylation passwords for activity-dependent gene expression. Neuron 34, 179182.
  • Doyle M. E., Theodorakis M. J., Holloway H. W., Bernier M., Greig N. H. and Egan J. M. (2003) The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity. Regul. Pept. 114, 153158.
  • During M. J., Cao L., Zuzga D. S., Fitzsimons H. L., Jiao Z., Bland R. J., Klugmann M., Banks W. A., Drucker D. J. and Haile C. N. (2003) Glucagon-like peptide-1 receptor involvement in learning and neuroprotection. Nat. Med. 9, 11731179.
  • Egan J. M., Clocquet A. R. and Elahi D. (2002) The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J. Clin. Endocrinol. Metab. 87, 12821290.
  • Flamez D., Gilon P., Moens K., Van Breusegem A., Delmeire D., Scrocchi L. A., Henquin J. C., Drucker D. J. and Schuit F. (1999) Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype. Diabetes 48, 19791986.
  • Furukawa K., Fu W., Li Y., Witke W., Kwiatkowski D. J. and Mattson M. P. (1997) The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 81788186.
  • Gary D. S. and Mattson M. P. (2002) PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis. Neuromolec. Med. 2, 261269.
  • Gilman C. P. and Mattson M. P. (2002) Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromolec. Med. 2, 197214.
  • Goke R., Larsen P. J., Mikkelsen J. D. and Sheikh S. P. (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7, 22942300.
  • Gomez E., Pritchard C. and Herbert T. P. (2002) cAMP dependent protein kinase and Ca++ influx through 1-type voltage gated calcium channels mediate Raf independent activation of extracellular regulated kinase in response to glucagon like peptide-1 in pancreatic beta-cells. J. Biol. Chem. 277, 4814648151.
  • Hamill O. P., Marty A., Neher E., Sakmann B. and Sigworth F. J. (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85100.
  • Holz G. G., Leech C. A. and Habener J. F. (1995) Activation of a cAMP-regulated Ca2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J. Biol. Chem. 270, 17 74917 757.
  • Holz G. G., Leech A. C., Heller R. S., Castonguay M. and Habener J. F. (1999) cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. J. Biol. Chem. 274, 14 14714 156.
  • Impey S., Obrietan K., Wong S. T., Poser S., Yano S., Wayman G., Deloulme J. C., Chan G. and Storm D. R. (1998) Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21, 869883.
  • Jarvis S. E. and Zamponi G. W. (2001) Interactions between presynaptic Ca2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. Trends Pharmacol. Sci. 22, 519525.
  • Kakei M., Yada T., Nakagawa A. and Nakabayashi H. (2002) Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons. Auton. Neurosci. 102, 3944.
  • Kanse S. M., Kreymann B., Ghatei M. A. and Bloom S. R. (1998) Identification and characterization of glucagon-like peptide-1, 7-36 amide-binding sites in the rat brain and lung. FEBS Lett. 241, 209212.
  • Kavalali E. T., Hwang K. S. and Plummer M. R. (1997) cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J. Neurosci. 17, 53345348.
  • Kemp D. M. and Habener J. F. (2002) Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications. Biochem. Pharmacol. 64, 689697.
  • Klockner U., Itagaki K., Bodi I. and Schwartz A. (1992) Beta-subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents. Pflugers Arch. 420, 413415.
  • Litherland G. J., Hajduch E. and Hundal H. S. (2001) Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (review). Mol. Membr. Biol. 18, 195204.
  • Lu C., Fu W. and Mattson M. P. (2002) Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolec. Med. 1, 6979.
  • Mabuchi T., Kitagawa K., Kuwabara K., Takasawa K., Ohtsuki T., Xia Z., Storm D., Yanagihara T., Hori M. and Matsumoto M. (2001) Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J. Neurosci. 21, 92049213.
  • Mattson M. P. (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolec. Med. 3, 6594.
  • Mattson M. P., Dou P. and Kater S. B. (1988a) Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8, 20872100.
  • Mattson M. P., Lee R. E., Adams M. E., Guthrie P. B. and Kater S. B. (1988b) Interactions between entorhinal axons and target hippocampal neurons: A role for glutamate in the development of hippocampal circuitry. Neuron 1, 865876.
  • Mattson M. P., Guthrie P. B. and Kater S. B. (1988c) Intracellular messengers in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. Res. 21, 447464.
  • Mattson M. P., Kumar K. N., Wang H., Cheng B. and Michaelis E. K. (1993) Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci. 13, 45754588.
  • Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth. Cell Biol. 46, 187216.
  • Mattson M. P., Perry T. and Greig N. (2003) Learning from the gut. Nat. Med. 9, 11131115.
  • Mermelstein P. G., Bito H., Deisseroth K. and Tsien R. W. (2000) Critical dependence of cAMP response element-binding protein phosphorylation on 1-type calcium channels supports a selective response to EPSPs in preference to action potentials. J. Neurosci. 20, 266273.
  • Nauck M. A., Heimesaat M. M., Behle K., Holst J. J., Nauck M. S., Ritzel R., Hufner M. and Schmiegel W. H. (2002) Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J. Clin. Endocrinol. Metab. 87, 12391246.
  • Nussdorfer G. G. and Malendowicz L. K. (1998) Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19, 14431467.
  • Oka J., Goto N., Goke R., Larsen P. J., Mikkelsen J. D. and Sheikh S. P. (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7, 22942300.
  • Oka J. I., Goto N. and Kameyama T. (1999) Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus. Neuroreport 10, 16431646.
  • Pak K., Chan S. L. and Mattson M. P. (2003) Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities and exacerbates which matter damage and memory impairment in mice. Neuromolec. Med. 3, 5364.
  • Parnas H., Segel L., Dudel J. and Parnas I. (2000) Autoreceptors, membrane potential and the regulation of transmitter release. Trends Neurosci. 23, 6068.
  • Pedersen W. A., McCullers D., Culmsee C., Haughey N. J., Herman J. P. and Mattson M. P. (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8, 492503.
  • Pedersen W. A., Wan R., Zhang P. and Mattson M. P. (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404412.
  • Perry T., Lahiri D. K., Chen D., Zhou J., Shaw K. T., Egan J. M. and Greig N. H. (2002a) A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J. Pharmacol. Exp. Ther. 300, 958966.
  • Perry T., Haughey N. J., Mattson M. P., Egan J. M. and Greig N. H. (2002b) Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J. Pharmacol. Exp. Ther. 302, 881888.
  • Perry T., Lahiri D. K., Sambamurti K., Chen D., Mattson M. P., Egan J. M. and Greig N. H. (2003) Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J. Neurosci. Res. 72, 603612.
  • Price C. J., Kim P. and Raymond L. A. (1999) Related Articles, Links Abstract D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. J. Neurochem. 73, 24412446.
  • Rajadhyaksha A., Barczak A., Macias W., Leveque J. C., Lewis S. E. and Konradi C. (1999) L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19, 63486359.
  • Raman I. M., Tong G. and Jahr C. E. (1996) Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16, 415421.
  • Rosenmund C., Carr D. W., Bergeson S. E., Nilaver G., Scott J. D. and Westbrook G. L. (1994) Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 368, 853856.
  • Satoh F., Beak S. A., Small C. J., Falzon M., Ghatei M. A., Bloom S. R. and Smith D. M. (2000) Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase. Endocrinology 141, 13011309.
  • Shoge K., Mishima H. K., Saitoh T., Ishihara K., Tamura Y., Shiomi H. and Sasa M. (1998) Protective effects of vasoactive intestinal peptide against delayed glutamate neurotoxicity in cultured retina. Brain Res. 809, 127136.
  • Stark A. and Mentlein R. (2002) Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells. Regul. Pept. 108, 97102.
  • Tsuboi T., da Silva Xavier G., Holz G. G., Jouaville L. S., Thomas A. P. and Rutter G. A. (2003) Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem. J. 369, 287299.
  • Wang J. H., Ko G. Y. and Kelly P. T. (1997) Cellular and molecular bases of memory: synaptic and neuronal plasticity. J. Clin. Neurophysiol. 14, 264293.
  • Wang Y., Perfetti R., Greig N. H., Holloway H. W., DeOre K. A., Montrose-Rafizadeh C., Elahi D. and Egan J. M. (1997) Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J. Clin. Invest. 99, 28832889.
  • Weisskopf M. G., Castillo P. E., Zalutsky R. A. and Nicoll R. A. (1994) Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265, 18781882.
  • Yamamoto H., Kishi T., Lee C. E., Choi B. J., Fang H., Hollenberg A. N., Drucker D. J. and Elmquist J. K. (2003) Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J. Neurosci. 23, 29392946.
  • Zhou C. J., Shioda S., Yada T., Inagaki N., Pleasure S. J. and Kikuyama S. (2002) PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr. Protein Pept. Sci. 3, 423439.
  • Zhou J., Pineyro M. A., Wang X., Doyle M. E. and Egan J. M. (2002) Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. J. Cell Physiol. 192, 304314.